Merial obtains preliminary injunction precluding sale of generic version of Frontline® Plus
Clients Merial Limited and Merial SAS
Jones Day successfully represented Plaintiffs Merial Limited and Merial SAS against Velcera Inc. and FidoPharm Inc. securing a preliminary injunction preventing the sale and distribution of generic versions of Merial's flagship FRONTLINE® Plus flea and tick products. In the Order granting the preliminary injunction, the Court explained that the Defendants' expert, who was cross-examined by Jones Day partner J. Patrick Elsevier, Ph.D., "was effectively impeached."
Merial Limited, et al. v. Velcera, Inc., et al., Civil Action No. 3-12-cv-00075 (Judge Land), 2012 BL 171582 (M.D. Ga. June 29, 2012)